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Netherlands; Edinburgh, United Kingdom; Baltimore, Md; Lausanne, Switzerland; Calgary, Alberta, Canada; and Perth, AustraliaThe concept of the neonatal window of opportunity assigns the
early postnatal period a critical role for lifelong host-microbial and
immune homeostasis. It is supported by epidemiological evidence
that links postnatal environmental exposure with disease suscep-
tibility and mechanisms in the neonate host that facilitate the
postnatal transposition, establish a stablemicrobiome, and promote
immune maturation. During the conference on ‘‘The neonatal
window of opportunity – early priming for life,’’ postnatal micro-
biome and immune maturation, epidemiological evidence, and
fundamental mechanisms were discussed to identify new targets
for future preventive and interventional measures.
From December 5 to 7, 2016, the Herrenhausen Conference
‘‘The neonatal window of opportunity – early priming for life’’
took place at Hannover, Germany, sponsored by the Volkswagen
Foundation. The concept of the ‘‘neonatal window of opportu-
nity,’’ that is, a critical nonredundant time frame in a newborn’s
life during which environmental factors drive immune and tissue
maturation and influence the susceptibility to immune-mediated
and other diseases in adult life, was discussed.
Please note: An extended version of this article can be found in
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1212NONCOMMUNICABLE DISEASES AS THE GRAND
CHALLENGE FOR PREVENTION
Our body is exposed continuously to many danger signals. An
effective immune system is essential to protect and repair.
Unbalanced immune reactivity seems to play a key role in
noncommunicable diseases such as chronic obstructive pulmonary
disease, allergies, asthma, diabetes, cancer, and cardiovascular
diseases as well as obesity. Prevention is the grand challenge,
because causal therapies for noncommunicable diseases are still not
available and prevalences and incidences are currently on the rise.MATERNAL/FETAL/NEONATAL INTERACTION
The first ‘‘window of opportunity’’ in life is defined as the
prenatal or perinatal period. Particularly in this period, microbial
factors have a strong impact on the development of immune
responses. This includes not only the birthplace and mode of
delivery, breast-feeding, medication (eg, antibiotic use), and
introduction of solid foods but also the exposure to siblings and
pets. Challenging the immune tolerance of neonatal mice, germ-
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FIG 1. Newmechanisms of microbe-immune interaction. For details please see text. iNKT, Invariant natural
killer T cells; TLR 4, Toll-like receptor 4.
J ALLERGY CLIN IMMUNOL
VOLUME 141, NUMBER 4
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mice. Once their airway microbiome had formed after 2 post-
natal weeks, the mice were protected against this overshooting
allergic inflammation.1 However, oral antigen administration in
early life, even in the presence of protective breast milk–derived
factors, does not guarantee the induction of oral tolerance and
the prevention of allergic disease. This implies the necessity to
identify limiting factors for oral tolerance induction in early
life.2
Healthy nutrition during pregnancy and early life represents a
key factor for proper immune development. Human milk still
remains the criterion standard.DEVELOPMENT OF IMMUNE TOLERANCE IN THE
NEONATAL PERIOD
This goes hand in hand with the ontogeny of the enteric
mucosal tissue and its influence on the establishment of the
enteric microbiota and long-term host-microbial homeostasis as
well as infection susceptibility. Age-dependently expressed
features of the innate and adaptive immune system contribute to
the postnatal acquisition of mucosal homeostasis and the
particular susceptibility of the neonate host to infection.3EARLY EVENTS AND NEW INSIGHTS INTO
MECHANISMS
Streptococcus pneumonia is a leading cause of bacterial infec-
tion of the upper and lower respiratory tract in children. This
pathogen spreads to its host following acquisition of very few or-
ganisms that quickly proliferate and dominate the niche in the
upper respiratory tract. This work established a new paradigm
for understanding pathogen transmission and the initial estab-
lishment of the colonizing microbiota in newborns. This is alsoinfluenced by the exposure to maternal microbiota metabolites
in utero and in early life during lactation that prepares the
newborn for colonization with its own microbiota and sets the
baseline for a regulated immune system.4 Important novel mech-
anisms are summarized in Fig 1. Neonates are often highly sus-
ceptible to intestinal pathogens. An exception is seen after
infection of murine neonates with Yersinia enterocolitica.
Here, multiple innate and adaptive components including (sur-
prisingly) CD81 T lymphocytes cells participate in protective
immunity. Natural killer T cells function as a kind of checkpoint
regulating the crosstalk between the microbiota and the immune
system. Invariant natural killer T cells are resident cells of the gut
mucosa that establish their niche during early life when they
home to and expand during a restricted period of neonatal life.
Studies performed in germ-free mice suggest a critical neonatal
time period for the development and proliferation of these im-
mune cells.5 gd cells in mice represent a first line of defense
with respect to both early in life during T-cell development and
ontogeny as well as in terms of mucosal tissue localization.
The human neonate gdTCR repertoire contains considerable fre-
quencies of innate ‘‘public’’ TCR-d sequences matching
conserved microbial structure. Symbiotic bacteria control the se-
lection processes that determine the antibody repertoire of naive
B cells in neonatal mice. Interestingly, this training event appears
to be particularly influential during a narrow window of opportu-
nity after birth as commensal bacteria exposure of adult germ-
free mice showed no effect on the positive selection events.
Tissue-specific memory T cells are established as noncirculating
resident memory T cells at various tissue sites in response to mi-
crobial stimulation.6 Necrotizing enterocolitis is the leading
cause of death from gastrointestinal disease in premature infants
and develops after an exuberant proinflammatory response to the
colonizing microbiota and this requires activation of the LPS re-
ceptor, Toll-like receptor 4.7
J ALLERGY CLIN IMMUNOL
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Epidemiological studies show a strong correlation between
early microbial exposure to allergens and a reduced risk of
hypersensitivity leading to asthma or hay fever later in life.8 The
diversity and duration of microbial exposure early in life are
important for the development of tolerogenic immune functions.
In this regard, mild proinflammatory signals including IL-6 play a
critical role to orchestrate early activation signals.9NEW METHODS
Stem cell–derived organoids represent a new 3-dimensional
model system of the gut epithelium that allows the study of organ
development, immune homeostasis, and tissue regeneration.
Moreover, epithelial stem cell organoids now also open the
possibilities to study host-microbe-interaction.
System biology approaches applied to the global transcriptome
generated from the RNA isolated from a few drops of blood from
preterm babies have helped to reveal how regulatory mechanisms
determine the set-point for immune homeostasis in early life by
integrating specific immune and metabolic pathways so that
interpatient differences can be overcome and uncovered a novel
immune-metabolic axis that accurately predicts sepsis in neonates
and infants. These studies lay the foundation for future translation
of host pathways in advancing diagnostic, prognostic, and
therapeutic strategies for neonatal sepsis.10CONCLUSIONS
We are only starting to appreciate the critical impact of the
postnatal period for lifelong health and disease susceptibility.
Recent discoveries provide the proof of principle, characterize the
critical time window(s), and identify underlying mechanisms.
However, a number of important questions remain: The cause-
effect relationship between microbial exposure and health needsto be established and the mechanisms operating during this
‘‘window of opportunity’’ need to be elucidated. This must
consequently lead to effective primary prevention strategies.
Future research will further deepen our understanding and extend
from animal models to human studies to develop interventional
strategies to foster immune homeostasis and prevent the
development of diseases.
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